Registrieren
E-Mail:
Passwort:
Ich akzeptiere die
Nutzungsbedingungen
Registrieren
Registierung erfolgt in Kürze...
query
ai
Login
Registrieren
Infos
Werben auf fleebs.com
Seite indizieren lassen
Einstellungen
Datenschutz
Nutzungsbedingungen
Impressum
Details werden geladen...
https://blockonomi.com/hims-hers-health-hims-stock-plunges-after-hours-on-q1-earnings-disappointment/
Teilen bei
Facebook
Teilen bei
Twitter
Teilen bei
Pinterest
Per Mail empfehlen
Hims & Hers Health (HIMS) Stock Plunges After Hours on Q1 Earnings Disappointment - Blockonomi
Hims & Hers (HIMS) stock dropped 9.75% after hours as Q1 losses widened and margins compressed, offsetting revenue gains and subscriber growth.
Ähnliche Seiten
Hims & Hers Health (HIMS) Stock Tumbles as Q1 Losses Eclipse Revenue Gains - MoneyCheck
https://moneycheck.com/hims-hers-health-hims-stock-tumbles-as-q1-losses-eclipse-revenue-gains/
Hims & Hers (HIMS) Stock Plunges 8% on Unexpected Q1 Loss and Revenue Shortfall - MoneyCheck
https://moneycheck.com/hims-hers-hims-stock-plunges-8-on-unexpected-q1-loss-and-revenue-shortfall/
Hims & Hers Health (HIMS) Q1 Earnings Preview: What Investors Need to Know - Blockonomi
https://blockonomi.com/hims-hers-health-hims-q1-earnings-preview-what-investors-need-to-know/
Hims earnings impact on Hims & Hers Health stock: Hims earnings today: Why Hims & Hers Health stock dropped despite raising revenue forecast - here's what investors need to know - The Economic Times
https://economictimes.indiatimes.com/news/international/us/hims-earnings-today-why-hims-hers-health-stock-dropped-despite-raising-revenue-forecast-heres-what-investors-need-to-know/articleshow/131023665.cms
Hims & Hers Health (HIMS) Stock: Q1 Earnings Preview and Key Metrics to Watch - MoneyCheck
https://moneycheck.com/hims-hers-health-hims-stock-q1-earnings-preview-and-key-metrics-to-watch/
CRISPR Therapeutics (CRSP) Stock Plunges 11% Amid Earnings Disappointment and Competitive Threat - Blockonomi
https://blockonomi.com/crispr-therapeutics-crsp-stock-plunges-11-amid-earnings-disappointment-and-competitive-threat/
Please enable JavaScript to continue using this application.